{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Initial Propofol Bolus Doses in Different TCI Pumps"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Two pumps employed a fixed equilibration rate constant (ke0) of 0.456 min\u22121, while the other two used a fixed time to peak concentration (tpeak) of 1.6 min."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aims to investigate whether differences exist in the initial bolus dose between different TCI pumps, despite using the same pharmacokinetic (PK) model."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the propofol bolus dose, measured on a high precision scale."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "For instance, a virtual 60-year-old, obese man received 72.0 \u00b1 1.0 mg with a Perfusor Space pump and 111.9 \u00b1 1.2 mg with an Alaris pump (P < 0.001)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 8,
    "max_score": 25
  },
  "model": "gpt-4o"
}